Maximus (NYSE:MMS) Posts Quarterly Earnings Results, Beats Estimates By $0.22 EPS

Maximus (NYSE:MMS) issued its quarterly earnings data on Thursday. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22, Zacks reports. Maximus had a net margin of 5.78% and a return on equity of 20.95%. Maximus updated its FY 2025 guidance to 5.900-6.200 EPS.

Maximus Price Performance

Shares of Maximus stock traded down $5.54 on Thursday, hitting $70.29. 1,700,525 shares of the company traded hands, compared to its average volume of 691,676. The stock has a market capitalization of $4.01 billion, a P/E ratio of 14.06 and a beta of 0.72. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. Maximus has a 52 week low of $69.72 and a 52 week high of $93.97. The business has a 50-day simple moving average of $74.87 and a 200 day simple moving average of $83.62.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.71%. The ex-dividend date is Friday, February 14th. Maximus’s payout ratio is currently 24.00%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on MMS shares. StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research note on Wednesday, January 29th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd.

Insider Activity

In related news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Bruce Caswell bought 3,500 shares of the business’s stock in a transaction that occurred on Tuesday, December 17th. The stock was acquired at an average cost of $70.64 per share, with a total value of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This represents a 1.28 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 7,063 shares of company stock worth $502,017 over the last quarter. Insiders own 1.60% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.